View by Specialty

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 03, 2024
1 min read
Save

Study: No clear association between pet ownership and brain, heart health

Study: No clear association between pet ownership and brain, heart health

ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.

SPONSORED CONTENT
October 02, 2024
3 min read
Save

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection

The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.

Trending

PC1124Murray_Graphic_01_WEB
November 22, 2024
3 min read
Save

‘Truly alarming’: Life expectancy gap in the US now up to 20 years

SPONSORED CONTENT
October 01, 2024
2 min read
Save

Tea, red wine among foods tied to lower risk for dementia

Tea, red wine among foods tied to lower risk for dementia

Adults who more frequently consumed several flavonoid-rich foods, like berries and tea, had a significantly lower risk for dementia, according to an analysis published in JAMA Network Open.

SPONSORED CONTENT
October 01, 2024
3 min read
Save

Gender, sexual identity may be associated with brain health outcomes

Gender, sexual identity may be associated with brain health outcomes

LGBTQ+ people may be more likely to experience adverse brain health outcomes, including late-life depression and dementia, compared with cisgender straight people, according to study results published in Neurology.

SPONSORED CONTENT
September 26, 2024
2 min read
Save

MIND diet may reduce the risk for cognitive decline

MIND diet may reduce the risk for cognitive decline

Higher adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND) diet reduced the risk for cognitive impairment, particularly in women, results from a cohort study published in Neurology showed.

SPONSORED CONTENT
September 26, 2024
4 min watch
Save

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation

PHILADELPHIA — In this Healio Video Perspective from the Alzheimer’s Association International Conference, Johan Luthman, PhD, discusses new data from post hoc analyses evaluating the efficacy of Rexulti for Alzheimer’s-related agitation.

SPONSORED CONTENT
September 25, 2024
2 min read
Save

One in three former professional football players believe they have CTE

One in three former professional football players believe they have CTE

Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.

SPONSORED CONTENT
September 25, 2024
1 min read
Save

FDA approves second Niemann-Pick disease type C treatment

FDA approves second Niemann-Pick disease type C treatment

The FDA has approved Aqneursa as an oral treatment for neurological symptoms associated with Niemann-Pick disease type C, a rare genetic disease, in adults and children weighing at least 15 kg, according to a press release.

SPONSORED CONTENT
September 24, 2024
2 min read
Save

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

Diabetes drug linked to reduced risk for dementia, Parkinson’s disease

The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.

SPONSORED CONTENT
September 20, 2024
2 min read
Save

FDA approves Miplyffa for Niemann-Pick disease type C

FDA approves Miplyffa for Niemann-Pick disease type C

The FDA announced in a press release that it has approved Miplyffa to treat neurological symptoms associated with Niemann-Pick disease type C in patients aged 2 years and older.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails